JP7275040B2 - Ｘｖｉｉｉ型コラーゲンアッセイ - Google Patents

Ｘｖｉｉｉ型コラーゲンアッセイ Download PDF

Info

Publication number
JP7275040B2
JP7275040B2 JP2019550764A JP2019550764A JP7275040B2 JP 7275040 B2 JP7275040 B2 JP 7275040B2 JP 2019550764 A JP2019550764 A JP 2019550764A JP 2019550764 A JP2019550764 A JP 2019550764A JP 7275040 B2 JP7275040 B2 JP 7275040B2
Authority
JP
Japan
Prior art keywords
collagen
antibody
time point
xviii
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019550764A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020514368A5 (https=
JP2020514368A (ja
Inventor
マノン－イェンセン，ティナ
カルスダル，モルテン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordic Bioscience AS
Original Assignee
Nordic Bioscience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordic Bioscience AS filed Critical Nordic Bioscience AS
Publication of JP2020514368A publication Critical patent/JP2020514368A/ja
Publication of JP2020514368A5 publication Critical patent/JP2020514368A5/ja
Application granted granted Critical
Publication of JP7275040B2 publication Critical patent/JP7275040B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
JP2019550764A 2017-03-16 2018-03-14 Ｘｖｉｉｉ型コラーゲンアッセイ Active JP7275040B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1704182.3A GB201704182D0 (en) 2017-03-16 2017-03-16 Collagen tye XVIII assay
GB1704182.3 2017-03-16
PCT/EP2018/056320 WO2018167111A1 (en) 2017-03-16 2018-03-14 Collagen type xviii assay

Publications (3)

Publication Number Publication Date
JP2020514368A JP2020514368A (ja) 2020-05-21
JP2020514368A5 JP2020514368A5 (https=) 2021-04-30
JP7275040B2 true JP7275040B2 (ja) 2023-05-17

Family

ID=58688412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019550764A Active JP7275040B2 (ja) 2017-03-16 2018-03-14 Ｘｖｉｉｉ型コラーゲンアッセイ

Country Status (6)

Country Link
US (2) US20200087385A1 (https=)
EP (1) EP3596120B1 (https=)
JP (1) JP7275040B2 (https=)
ES (1) ES2969042T3 (https=)
GB (1) GB201704182D0 (https=)
WO (1) WO2018167111A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201901710D0 (en) * 2019-02-07 2019-03-27 Nordic Bioscience As Collagen type 23 assay
GB202019578D0 (en) * 2020-12-11 2021-01-27 Nordic Bioscience As Assay for detecting Collagen XVIII biomarkers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049749A1 (ja) 2005-10-28 2007-05-03 Dnavec Corporation 血液凝固異常の治療方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049749A1 (ja) 2005-10-28 2007-05-03 Dnavec Corporation 血液凝固異常の治療方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Am. J. Pathol.，1998年，Vol. 153，pp. 611-626
J. Thromb. Haemost.，2016年，Vol. 14，pp. 438-448
Matrix Biol.，1998年，Vol. 16，pp. 319-328
Matrix Biol.，2003年，Vol. 22，pp. 427-442
Matrix Biol.，2011年，Vol. 30，pp. 83-92

Also Published As

Publication number Publication date
EP3596120B1 (en) 2023-12-13
WO2018167111A1 (en) 2018-09-20
US20200087385A1 (en) 2020-03-19
EP3596120C0 (en) 2023-12-13
JP2020514368A (ja) 2020-05-21
EP3596120A1 (en) 2020-01-22
ES2969042T3 (es) 2024-05-16
US20230340092A1 (en) 2023-10-26
GB201704182D0 (en) 2017-05-03

Similar Documents

Publication Publication Date Title
JP6408051B2 (ja) 病理学バイオマーカーアッセイ
JP6757252B2 (ja) 血漿カリクレイン系バイオマーカーを決定するためのアッセイ
US9835631B2 (en) Combined biomarker measurement of fibrosis
US20160061844A1 (en) PIIINP Neo-epitope Assay
Nielsen et al. Tumstatin, a matrikine derived from collagen type IVα3, is elevated in serum from patients with non–small cell lung cancer
JP2020022515A (ja) フォンビルブランド因子のａｄａｍｔｓ１３媒介インビボ切断を測定する方法およびその使用
US20230340092A1 (en) Collagen Type XVIII Assay
Kjeld et al. The endothelial specific isoform of type XVIII collagen correlates to annual bleeding rate in haemophilia patients
JP2019510210A (ja) 線維症の組み合わせたバイオマーカー測定
JP7699608B2 (ja) 線維症のバイオマーカー
JP6505749B2 (ja) 肺疾患および他の疾患用の生化学マーカー
US20220227848A1 (en) Type XXIII Collagen Assay
Manon-Jensen et al. Initiation of the wound healing cascade in inflammatory bowel disease: assessment of Von Willebrand factor ADAMTS-13 processing and formation in crohn’s disease
JP7169356B2 (ja) Ｓｐａｒｃアッセイ
US20200340994A1 (en) Tumstatin Assay
JP2025541243A (ja) フォン・ヴィレブランド因子ａ３ドメインを標的とする単一ドメイン抗体
US20190257837A1 (en) Nidogen-1 Fragments Assay
AU2015203448A1 (en) Methods of Measuring ADAMTS13-Mediated in Vivo Cleavage of Von Willebrand Factor and Uses Thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210311

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20211222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220105

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220328

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220603

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220927

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221214

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230324

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230404

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230502

R150 Certificate of patent or registration of utility model

Ref document number: 7275040

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150